WEC
BIVV

Winslow Evans & Crocker’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Winslow Evans & Crocker’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-788
Closed -$42.5K – 1172
2017
Q4 		$42.5K Sell
788
-306
-28% -$16.7K 0.01% 523
2017
Q3 		$62.4K Sell
1,094
-815
-43% -$47.7K 0.02% 435
2017
Q2 		$110K Buy
1,909
+1,099
+136% +$62.6K 0.03% 418
2017
Q1 		$44.1K Buy
+810
New +$39.9K 0.01% 559

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Winslow Evans & Crocker's BIVV Position: Q1 2018 in Review

Winslow Evans & Crocker sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 788 shares — an estimated $42.5K sold.

Winslow Evans & Crocker first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $110K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Winslow Evans & Crocker reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Winslow Evans & Crocker sold 788 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $42.5K.
  • Winslow Evans & Crocker first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Winslow Evans & Crocker's Bioverativ Inc. Common Stock position peaked at $110K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Winslow Evans & Crocker's 13F filing for Q1 2018, filed 26 Apr 2018.